NEUREN PHARMACEUTICALS
Neuren Pharmaceuticals Limited is a biopharmaceutical company developing drugs for brain injury and neurodegeneration. The drugs target acute indications of brain injury such as traumatic brain injury, as well as chronic conditions such as Parkinson’s and Alzheimer’s diseases. Neuren is also engaged in research and development in metabolic disorders such as cancers related to the functions of growth hormone. Neuren has three lead candidates; Motiva™ and NNZ-2566 presently in clinical de... velopment to treat three different neurological conditions, and NNZ-2591 in preclinical development for Parkinson’s disease dementia and other chronic neurodegenerative conditions. Neuren has operations in New Zealand (Auckland based head office), Australia and the United States, and is listed on the Australian Securities Exchange (ASX: NEU).
NEUREN PHARMACEUTICALS
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2004-01-01
Address:
Camberwell South, Victoria, Australia
Country:
Australia
Website Url:
http://www.neurenpharma.com
Total Employee:
11+
Status:
Active
Contact:
+61390920480
Email Addresses:
[email protected]
Total Funding:
21.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Content Delivery Network Font Awesome Microsoft Exchange Online Amazon
Similar Organizations
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Advisors List
Current Employees Featured
Stock Details
Official Site Inspections
http://www.neurenpharma.com Semrush global rank: 4.52 M Semrush visits lastest month: 2.36 K
- Host name: a290d26420470737c.awsglobalaccelerator.com
- IP address: 15.197.133.181
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
